Scientific Programme & Abstracts from the International Meeting in Pediatric Endocrinology (IMPE)

impe0096p86 | GH and IGFs | IMPE2023

Impact on IGF1R and RANKL expression and IGF-1 and IGFBP-3 serum levels of zoledronic acid treatment compared with pamidronate in children with Osteogenesis Imperfecta.

Lima Guilherme , Martinelli Jr. Carlos

Osteogenesis imperfecta (OI) is a genetic disease characterized by alterations in type I collagen, which determine a broad spectrum of clinical alterations. Although there is no specific treatment, drugs of the bisphosphonate class are used with the aim of improving bone quality with a reduction in fracture events and a gain in quality of life. In Brazil, current protocols use pamidronate, a second-generation bisphosphonate. The use of zoledronic acid, a third-generation bisph...

impe0096fc13.3 | Adrenals and HPA Axis 2 | IMPE2023

Differential methylation of CYP11B1 in girls with high DHEAS levels

Rodríguez Fernando , Ponce Diana , Patricio Miranda José , Luis Santos José , B. Cutler Jr Gordon , Pereira Ana , Iñiguez Germán , Mericq Verónica

Context: Premature adrenarche in girls is defined biochemically by an increase in adrenal androgen (DHEA and DHEAS) levels above the age-specific reference range before age 8 years. Recently, increased levels of 11-oxyandrogens have also been observed in girls with premature adrenarche. On the other hand, epigenetic control of some genes that code for enzymes that participate in the synthetic pathway to 11-oxyandrogens (e.g., CYP11B1) has been describ...